Your browser doesn't support javascript.
loading
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.
Berner, Fiamma; Bomze, David; Diem, Stefan; Ali, Omar Hasan; Fässler, Mirjam; Ring, Sandra; Niederer, Rebekka; Ackermann, Christoph J; Baumgaertner, Petra; Pikor, Natalia; Cruz, Cristina Gil; van de Veen, Willem; Akdis, Mübeccel; Nikolaev, Sergey; Läubli, Heinz; Zippelius, Alfred; Hartmann, Fabienne; Cheng, Hung-Wei; Hönger, Gideon; Recher, Mike; Goldman, Jonathan; Cozzio, Antonio; Früh, Martin; Neefjes, Jacques; Driessen, Christoph; Ludewig, Burkhard; Hegazy, Ahmed N; Jochum, Wolfram; Speiser, Daniel E; Flatz, Lukas.
Afiliación
  • Berner F; Microbiology and Immunology PhD Program, University of Zurich, Zurich, Switzerland.
  • Bomze D; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Diem S; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Ali OH; Department of Oncology and Haematology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Fässler M; Department of Oncology and Haematology, Spital Grabs, Grabs, Switzerland.
  • Ring S; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Niederer R; Department of Oncology and Haematology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Ackermann CJ; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Baumgaertner P; Department of Dermatology and Allergology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Pikor N; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Cruz CG; Department of Dermatology and Allergology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • van de Veen W; Microbiology and Immunology PhD Program, University of Zurich, Zurich, Switzerland.
  • Akdis M; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Nikolaev S; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Läubli H; Department of Dermatology and Allergology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Zippelius A; Department of Oncology and Haematology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Hartmann F; Department of Oncology, Ludwig Cancer Research, University of Lausanne, Lausanne, Switzerland.
  • Cheng HW; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Hönger G; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Recher M; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.
  • Goldman J; Christine Kühne - Center for Allergy Research and Education, Davos, Switzerland.
  • Cozzio A; Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.
  • Früh M; Gustave Roussy Cancer Campus, Villejuif, France.
  • Neefjes J; University Paris 7, St Louis Hospital, Paris, France.
  • Driessen C; Cancer Immunology Laboratory, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Ludewig B; Division of Oncology, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Hegazy AN; Cancer Immunology Laboratory, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Jochum W; Division of Oncology, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Speiser DE; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
  • Flatz L; Institute of Immunobiology, Kantonsspital St Gallen, St Gallen, Switzerland.
JAMA Oncol ; 5(7): 1043-1047, 2019 Jul 01.
Article en En | MEDLINE | ID: mdl-31021392
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Pulmonares / Antígenos de Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Receptor de Muerte Celular Programada 1 / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Pulmonares / Antígenos de Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Año: 2019 Tipo del documento: Article País de afiliación: Suiza